These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38904389)

  • 21. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
    Derbyshire ER; Prudêncio M; Mota MM; Clardy J
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8511-6. PubMed ID: 22586124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
    Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
    PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.
    van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM
    PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In-vitro susceptibility and ex-vivo evaluation of macrocyclic lactone endectocides sub-lethal concentrations against Plasmodium vivax oocyst development in Anopheles arabiensis.
    Zeleke G; Duchateau L; Yewhalaw D; Suleman S; Devreese M
    Malar J; 2024 Jan; 23(1):26. PubMed ID: 38238768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects.
    Rendic SP
    Arch Toxicol; 2021 May; 95(5):1535-1546. PubMed ID: 33719007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
    Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
    Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax.
    March S; Ng S; Velmurugan S; Galstian A; Shan J; Logan DJ; Carpenter AE; Thomas D; Sim BK; Mota MM; Hoffman SL; Bhatia SN
    Cell Host Microbe; 2013 Jul; 14(1):104-15. PubMed ID: 23870318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting liver stage malaria with metformin.
    Vera IM; Grilo Ruivo MT; Lemos Rocha LF; Marques S; Bhatia SN; Mota MM; Mancio-Silva L
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31852843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonal human hepatocytes are differentially permissive to Plasmodium falciparum malaria parasites.
    Yang ASP; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GA; Graumans W; de Wilt JHW; Sauerwein RW
    EMBO J; 2021 Mar; 40(6):e106583. PubMed ID: 33459428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Rare, the Best: Spread of Antimalarial-Resistant Plasmodium falciparum Parasites by
    Berry A; Menard S; Nsango SE; Abate L; Concordet D; Tchioffo Tsapi M; Iriart X; Awono-Ambéné PH; Roche B; Morlais I
    Microbiol Spectr; 2021 Oct; 9(2):e0085221. PubMed ID: 34668767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi.
    Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Durand S; Smith ES; Baldeviano GC; Gerbasi RV; Ballard SB; Stoops CA; Vásquez GM
    Malar J; 2017 Nov; 16(1):474. PubMed ID: 29162101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax.
    Cui L; Trongnipatt N; Sattabongkot J; Udomsangpetch R
    Methods Mol Biol; 2009; 470():263-73. PubMed ID: 19089388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
    Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites.
    Dorjsuren D; Eastman RT; Wicht KJ; Jansen D; Talley DC; Sigmon BA; Zakharov AV; Roncal N; Girvin AT; Antonova-Koch Y; Will PM; Shah P; Sun H; Klumpp-Thomas C; Mok S; Yeo T; Meister S; Marugan JJ; Ross LS; Xu X; Maloney DJ; Jadhav A; Mott BT; Sciotti RJ; Winzeler EA; Waters NC; Campbell RF; Huang W; Simeonov A; Fidock DA
    Sci Rep; 2021 Jan; 11(1):2121. PubMed ID: 33483532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Plasmodium Liver Infection by Ivermectin.
    Mendes AM; Albuquerque IS; Machado M; Pissarra J; Meireles P; Prudêncio M
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
    Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.
    Bosson-Vanga H; Franetich JF; Soulard V; Sossau D; Tefit M; Kane B; Vaillant JC; Borrmann S; Müller O; Dereuddre-Bosquet N; Le Grand R; Silvie O; Mazier D
    Malar J; 2018 Apr; 17(1):143. PubMed ID: 29615050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
    Kanatani S; Elahi R; Kanchanabhogin S; Vartak N; Tripathi AK; Prigge ST; Sinnis P
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0041822. PubMed ID: 35943271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK
    Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.